GSA Capital Partners’s Dova Pharmaceuticals DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-61,632
Closed -$1.29M – 1935
2018
Q3
$1.29M Buy
+61,632
New +$1.47M 0.07% 505

Other funds holding DOVA

GSA Capital Partners's DOVA Position: Q4 2018 in Review

GSA Capital Partners sold out of Dova Pharmaceuticals (DOVA) in Q4 2018, closing a stake of 61,632 shares — an estimated $1.29M sold.

GSA Capital Partners first reported a position in DOVA in Q3 2018 and held it in 1 quarter. The position peaked at $1.29M in Q3 2018. 58 funds tracked by Wall St. Rank hold DOVA as of Q4 2018.

  • GSA Capital Partners reported no remaining Dova Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • GSA Capital Partners sold 61,632 Dova Pharmaceuticals shares in Q4 2018, an estimated $1.29M.
  • GSA Capital Partners first reported a position in Dova Pharmaceuticals in Q3 2018 and held it in 1 quarter.
  • GSA Capital Partners's Dova Pharmaceuticals position peaked at $1.29M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q4 2018.

Based on GSA Capital Partners's 13F filing for Q4 2018, filed 12 Feb 2019.